PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: a systematic review and meta-analysis

Immunotherapy ◽

10.2217/imt-2018-0198 ◽

2019 ◽

Vol 11 (10) ◽

pp. 921-930 ◽

Author(s):

Antonio Rossi ◽

Vincenzo Di Noia ◽

Anastasios Gkountakos ◽

Ettore D’Argento ◽

Giulia Sartori ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

86P Post-operative radiotherapy (PORT) vs non-PORT in non-small cell lung cancer patients: A systematic review and meta-analysis

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(21)01928-6 ◽

2021 ◽

Vol 16 (4) ◽

pp. S742

Author(s):

A. Hadisurya ◽

F. Tandy ◽

M. Suciningtias ◽

R.S. Heriyanto ◽

C. Chrystelle ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Diabetes mellitus and survival of non‐small cell lung cancer patients after surgery: A comprehensive systematic review and meta‐analysis

Thoracic Cancer ◽

10.1111/1759-7714.12985 ◽

2019 ◽

Vol 10 (3) ◽

pp. 571-578 ◽

Author(s):

Han‐Yu Deng ◽

Xi Zheng ◽

Panpan Zha ◽

Lei Peng ◽

Kai‐Li Huang ◽

...

Keyword(s):

Diabetes Mellitus ◽

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Frequency of the acquired resistant mutation T790 M in non-small cell lung cancer patients with active exon 19Del and exon 21 L858R: a systematic review and meta-analysis

10.1186/s12885-018-4075-5 ◽

2018 ◽

Vol 18 (1) ◽

Author(s):

Zan-Feng Wang ◽

Sheng-Xiang Ren ◽

Wei Li ◽

Guang-Hui Gao

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Resistant Mutation

Download Full-text

Clinicopathological and Demographical Characteristics of Non-Small Cell Lung Cancer Patients with ALK Rearrangements: A Systematic Review and Meta-Analysis

PLoS ONE ◽

10.1371/journal.pone.0100866 ◽

2014 ◽

Vol 9 (6) ◽

pp. e100866 ◽

Author(s):

Liang Fan ◽

Yun Feng ◽

Huanying Wan ◽

Guochao Shi ◽

Wenquan Niu

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

The incidence of ALK inhibitor-related pneumonitis in advanced non-small-cell lung cancer patients: A systematic review and meta-analysis

Lung Cancer ◽

10.1016/j.lungcan.2019.04.015 ◽

2019 ◽

Vol 132 ◽

pp. 79-86 ◽

Author(s):

Chong Hyun Suh ◽

Kyung Won Kim ◽

Junhee Pyo ◽

Hiroto Hatabu ◽

Mizuki Nishino

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Download Full-text

Kanglaite injection plus chemotherapy versus chemotherapy alone for non-small cell lung cancer patients: A systematic review and meta-analysis

Current Therapeutic Research ◽

10.1016/j.curtheres.2008.10.004 ◽

2008 ◽

Vol 69 (5) ◽

pp. 381-411 ◽

Author(s):

Xuemei Liu ◽

Feng Xu ◽

Gang Wang ◽

Xiang Diao ◽

Youping Li

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

1358P Efficacy and toxicity of combined inhibition of EGFR and VEGFR in advanced non-small cell lung cancer patients harboring activating EGFR mutations: A systematic review and meta-analysis

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1672 ◽

2020 ◽

Vol 31 ◽

pp. S870

Author(s):

J. Deluce ◽

D. Maj ◽

G. Boldt ◽

D. Breadner ◽

J. Raphael

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Egfr Mutations ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

An audit of toxicity from first-line immunotherapy in inoperable or metastatic non-small cell lung cancer patients divided by ECOG performance status

Lung Cancer ◽

10.1016/s0169-5002(20)30157-4 ◽

2020 ◽

Vol 139 ◽

pp. S56

Author(s):

M. Gibb ◽

S. Massalha ◽

C. Bale

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Performance Status ◽

Small Cell Lung ◽

Ecog Performance Status ◽

Lung Cancer Patients

Download Full-text

MA14.06 Nintedanib-Docetaxel in 2nd Line Treatment in No Squamous Non-Small Cell Lung Cancer Patients, Refractory to First Line Treatment (GFPC02-15)

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.614 ◽

2019 ◽

Vol 14 (10) ◽

pp. S306-S307

Author(s):

J.B. Auliac ◽

I. Monnet ◽

A. Bizieux ◽

L. Greillier ◽

L. Falchero ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Line Treatment ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

First Line Treatment

Download Full-text

Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis

World Journal of Surgical Oncology ◽

10.1186/s12957-016-0992-4 ◽

2016 ◽

Vol 14 (1) ◽

Author(s):

Zi-Xue Xuan ◽

Su Zhang ◽

Shou-Jun Yuan ◽

Wei Wang ◽

Jia Yu

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Prognostic Value ◽

Meta Analysis ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Download Full-text